Failure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer
Journal of Surgical Oncology,

Lim SB et al. – More than one–third of patients with locally advanced rectal cancer showed good response to CRT, with improved local and systemic recurrence rates, especially low rates of pulmonary and systemic lymph node recurrence. Recurrence occurred earlier in the GR than the PR group, and oncologic outcomes after recurrence did not differ between the two groups.

  • Response to CRT was evaluated according to tumor regression grade (TRG), with 581 patients categorized into two groups, a good response (GR, TRG 3/4, n=224) and a poor response (PR, TRG 1/2, n=357) group.

  • At a mean follow–up of 61 months, the 5–year overall (88.2% vs. 71.3%, P<0.001) and disease–free (86.7% vs. 63.6%, P<0.001) survival rates were higher in the GR group.
  • In patients with recurrence, time to recurrence was shorter (13.5 months vs. 18.7 months, P=0.01), and the cumulative 2–year recurrence rates (92.9% vs. 73.4%, P=0.024) was higher in the GR group.
  • Rates of local (1.3% vs. 9.5% P<0.001) and systemic (11.6% vs. 27.2%, P<0.001) recurrence were significantly lower in the GR group, as were rates of pulmonary (3.6% vs. 15.1%, P<0.001) and systemic lymph node (1.3% vs. 5.9%, P=0.009) recurrences.
  • The 5–year overall survival rates after recurrence were similar (GR: 23.7% vs. PR: 16.0%, P=0.911).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Prognosis of stage II and III colon carcinoma treated with adjuvant 5-FU or FOLFIRI in relation to microsatellite status, results of the PETACC-3 trial Annals of Oncology, November 10, 2014    Clinical Article

2 Targeted therapies in metastatic colorectal cancer: A systematic review and assessment of currently available data Full Text The Oncologist, November 6, 2014    Free full text    Review Article

3 FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): A pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomised phase 3 trial Annals of Oncology, November 21, 2014    Clinical Article

4 Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: A pooled analysis of individual patient data from four randomised controlled trials The Lancet Oncology, November 26, 2014    Clinical Article

5 The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection Medical Oncology, October 13, 2014    Review Article

6 Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer, November 24, 2014    Clinical Article
Exclusive Author Commentary

7 Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response—a retrospective study Journal of Cancer Research & Clinical Oncology, October 31, 2014    Clinical Article

8 Colonic diverticulitis in chemotherapy patients: Should operative indications change? A retrospective cohort study International Journal of Surgery, November 26, 2014    Clinical Article

9 Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): An open-label, multicentre, phase 2, randomised controlled trial The Lancet Oncology, September 16, 2014    Clinical Article

10 Intensive follow-up strategies improve outcomes in non-metastatic colorectal cancer patients after curative surgery. A systematic review and meta-analysis Annals of Oncology, November 25, 2014    Review Article

11 MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine/threonine-protein kinase Tumor Biology, November 19, 2014    Clinical Article

12 Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation Full Text World Journal of Gastroenterology, November 19, 2014    Free full text    Clinical Article

13 Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer Annals of Surgical Oncology, September 22, 2014    Clinical Article

14 Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer Full Text World Journal of Gastroenterology, November 13, 2014    Free full text    Clinical Article

15 Efficacy of Anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy Clinical Cancer Research, October 23, 2014    Clinical Article

16 The value of pre-operative computed tomography scanning for the assessment of lymph node status in patients with colon cancer European Journal of Surgical Oncology, October 30, 2014    Review Article

17 Perineal transanal approach: A new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial Annals of Surgery, November 20, 2014    Clinical Article

18 Dietary supplement use and colorectal cancer risk: A systematic review and meta-analyses of prospective cohort studies International Journal of Cancer, November 7, 2014    Evidence Based Medicine    Review Article

19 C-reactive protein and risk of colorectal adenomas or serrated polyps: A prospective study Cancer Prevention Research, November 5, 2014    Clinical Article

20 Long-term oncologic results of laparoscopic D3 lymphadenectomy with complete mesocolic excision for right-sided colon cancer with clinically positive lymph nodes Surgical Endoscopy, November 17, 2014    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore